Company Information


BioRestorative Therapies, Inc. develops therapeutic products using cell and tissue protocols, primarily involving adult stem cells. Our two core programs relate to the treatment of disc/spine disease and metabolic disorders.

Forward Looking Statements

Statements in this presentation, including the information set forth as to the future financial or operating performance of BioRestorative Therapies, Inc. (the “Company”), that are not current or historical factual statements may constitute “forward looking” information within the meaning of securities laws. 

When used in this presentation, such statements may include, among other terms:

  • ‍such words as “may,” “will,” “expect,” “believe,” “plan,” “anticipate,” “intend,” “estimate,” “project,” “target” and other similar terminology. 
  • These statements reflect current expectations, estimates and projections regarding future events and operating performance and speak only as to the date of this presentation. 
  • Readers should not place undue importance on forward looking statements and should not rely upon this information as of any other date. 


BioRestorative Therapies' combined Management Team, Board of Directors and Scientific Advisory Board members have extensive experience in the healthcare industry. Together we have expert experience in the stem cell science, medical-related services, life science services marketing, public company business management and financing, IP development and licensing, business acquisitions, and strategic partnering.

Mark R. Weinreb, M.S.

Chief Executive Officer, President and Chairman

Mandy D. Clyde

Vice President of Operations and Corporate Secretary

Francisco Silva

Vice President of Research and Development and Chief Scientist

Edward Field, MBA

President of Disc/Spine Division

Robert Paccasassi

Vice President, Quality and Compliance

SEC Filings for BioRestorative Therapies Inc.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form

Contact Us

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form

Latest News & Press Releases